Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01278446 · ClinicalTrials.gov registry record · NA
Extensively Hydrolyzed Formula: Hypoallergenicity
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
NCT01278446: Completed NA study, sponsored by Société des Produits Nestlé (SPN).
NCT01278446 is a NA study that has completed, run by Société des Produits Nestlé (SPN). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01278446, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
The primary objective of this clinical trial is to determine whether a new extensively hydrolyzed infant formula is hypoallergenic.
Primary Outcome
To demonstrate that the test formula does not provoke allergenic activity
Interventions
- OTHER Extensively hydrolyzed, whey protein infant formula
- OTHER Extensively hydrolyzed, casein protein infant formula
Trial Details
| Field | Value |
|---|---|
| Start Date | 2011-02 |
| Est. Completion | 2012-08 |
| Phase | NA |
What the finished NCT01278446 record still lists
NCT01278446 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 2 interventions - of which Extensively hydrolyzed, whey protein infant formula is the first listed.
NCT01278446 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01278446 about?
NCT01278446 is a clinical study titled "Extensively Hydrolyzed Formula: Hypoallergenicity". The primary objective of this clinical trial is to determine whether a new extensively hydrolyzed infant formula is hypoallergenic.
What is the current status of trial NCT01278446?
This trial is currently completed. It is a NA study. The study started on 2011-02. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01278446?
The interventions under investigation include: Extensively hydrolyzed, whey protein infant formula (OTHER), Extensively hydrolyzed, casein protein infant formula (OTHER).
Who is sponsoring clinical trial NCT01278446?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia